Works from 2025
Educational impact of a podcast curriculum for hematology/oncology fellows: Final results of the multicenter cluster randomized PODCAST-HOF trial, Vivek G. Patel, Karine Tawagi, Samantha A. Armstrong, et al. (Article)
Immune Checkpoint Inhibitor Complications in Triple Negative Breast Cancer: Evaluating Oncologist Monitoring and Management of Adrenal Insufficiency and Hypophysitis, Stephen Smetana DO, Daniel Mundt MD, Magdalena Flejsierowicz MD, and James Adefisoye PhD (Oral/Podium Presentation)
Works from 2024
A multicenter analysis evaluating educational resources utilized by hematology/oncology fellows (HOF), Ronak Mistry, Inas Abuali, Ankoor Biswas, et al. (Abstract)
Utility of a collaborative hematology oncology (HO) podcast series for post-ASCO updates and teaching critical appraisal, Megan Connor, Samantha Ann Armstrong, Ankoor Biswas, et al. (Abstract)
Somatic POLE mutation and ultra-hypermutated genotype in a de novo high-grade, isocitrate dehydrogenase wild-type glioma: Treatment implications, Daniel Mundt, Isaac Melguizo-Gavilanes, Anil Y. Tumu, et al. (Article)
Works from 2022
18-year-old presenting with non-specifical abdominal/back pain diagnosed with metastatic EBV nasopharyngeal carcinoma, Kazi Khan, Abdul Aziz Siddiqui, and Ankoor Biswas (Poster)
Hyperglycemia-Induced osmotic demyelination syndrome in a type 2 diabetic with stable serum sodium, Jesse Galuk, Ian Kuckelman, and Ankoor Biswas (Poster)